Patent · US Active

Salts and crystals of ITI-007

US10654854B2 · kind B2 · utility

24Cited by

72References

18Claims

0Family size

Assignee

INTRA-CELLULAR THERAPIES, INC. · US

Inventors

Peng Li · New York, US
Edwin Aret · Almere, NL

Key dates

Filing date	Mar 28, 2017
Grant date	May 19, 2020
Priority date	—
Expiry date	Mar 28, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure provides new, stable, pharmaceutically acceptable salt forms of 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one, together with methods of making and using them, and pharmaceutical compositions comprising them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.